​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast

Boston Scientific (BSX) stock forecast, based on 43 Wall Street analysts, predicts a 12-month average price target of $127.00, with a high of $140.00 and a low of $110.00. This represents a 23.99% increase from the last price of $102.43.

- $30 $60 $90 $120 $150 High: $140 Avg: $127 Low: $110 Last Closed Price: $102.43

BSX Stock Rating

Boston Scientific stock's rating consensus is Buy, based on 43 Wall Street analysts. The breakdown includes 2 Strong Buy (4.65%), 38 Buy (88.37%), 3 Hold (6.98%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 43 0 3 38 2 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks

TypeNameUpside
StockBoston Scientific23.99%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks18.84%

Price Target Trends

1M3M12M
# Anlaysts111220
Avg Price Target$128.73$128.42$123.35
Last Closing Price$102.43$102.43$102.43
Upside/Downside25.68%25.37%20.42%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 257252--34
Sep, 256243--33
Aug, 256243--33
Jul, 258232-134
Jun, 258233--34
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2025Truist Financial$130.00$103.5325.57%26.92%
Oct 23, 2025Patrick WoodMorgan Stanley$130.00$103.8525.18%26.92%
Oct 23, 2025UBS$140.00$104.2434.31%36.68%
Oct 23, 2025Wells Fargo$125.00$104.2419.92%22.03%
Oct 22, 2025Goldman Sachs$124.00$103.8519.40%21.06%
Oct 07, 2025Evercore ISI$110.00$96.7013.75%7.39%
Oct 02, 2025Barclays$136.00$95.8541.89%32.77%
Oct 01, 2025Richard NewitterTruist Financial$129.00$94.1537.02%25.94%
Oct 01, 2025BTIG$132.00$97.6335.20%28.87%
Oct 01, 2025Robert W. Baird$128.00$97.6331.11%24.96%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2025Morgan StanleyOverweightOverweighthold
Oct 23, 2025UBSBuyBuyhold
Oct 23, 2025Wells FargoOverweightOverweighthold
Oct 22, 2025Goldman SachsBuyBuyhold
Oct 22, 2025Evercore ISIOutperformOutperformhold
Oct 02, 2025BarclaysOverweightOverweighthold
Oct 01, 2025BTIGBuyBuyhold
Sep 08, 2025OppenheimerOutperformOutperformupgrade
Jul 24, 2025RBC CapitalOutperformOutperformhold
Jul 21, 2025Raymond JamesStrong BuyStrong Buyhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.10$0.69$0.45$1.08$1.26----
Avg Forecast$1.04$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.07$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.03$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-109.62%-57.14%-73.99%-46.27%-48.99%----

Revenue Forecast

$5B $10B $15B $20B $25B $30B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.91B$11.89B$12.68B$14.24B$16.75B----
Avg Forecast$10.03B$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$10.21B$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$9.91B$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %-1.15%0.12%-0.02%0.88%0.83%----

Net Income Forecast

$-500M $1B $3B $4B $6B $7B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-140.00M$1.04B$698.00M$1.59B$1.85B----
Avg Forecast$1.53B$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.56B$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$1.50B$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %-109.16%9.89%-23.22%1.46%-48.65%----

BSX Forecast FAQ

Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 43 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 38 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 43 Wall Street analysts, averages $127 over the next 12 months. The price target range spans from $110 at the low end to $140 at the high end, suggesting a potential 23.99% change from the previous closing price of $102.43.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 23.99% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (18.84%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • October 2025: 20.59% Strong Buy, 73.53% Buy, 5.88% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 18.18% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 18.18% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2025 is $2.81, marking a 123.02% increase from the reported $1.26 in 2024. Estimates for the following years are $3.2 in 2026, $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2025 is $18.79B, reflecting a 12.21% increase from the reported $16.75B in 2024. The forecast for 2026 is $20.7B, followed by $22.61B for 2027, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2025 stands at $4.11B, representing an 121.97% increase from the reported $1.85B in 2024. Projections indicate $4.68B in 2026, $3.93B in 2027, and $5.8B in 2028.